Liver Diseases  >>  sirolimus  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus / Generic mfg.
NCT01374750: Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

Completed
2
45
RoW
Sirolimus, Rapamune, m-TOR inhibitor free, Tacrolimus, Cyclosporine
Seoul National University Hospital
Hepatocellular Carcinoma
05/16
05/16
Treg Liver Study, NCT02166177: Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients

Completed
1/2
9
Europe
Autologous regulatory T cell product
Guy's and St Thomas' NHS Foundation Trust, King's College London
End-stage Liver Disease
01/18
01/18

Download Options